Latest news

This year’s King Olav V’s Prize for Cancer Research will go to Professor Bjørn Tore Gjertsen, one of CONNECT’s Steering Committee...

Norge står i en internasjonal særstilling for å kunne samarbeide godt i helsesektoren, men det krever at politikerne tør å satse, skriver...

Connect had the pleasure of participating at Arendalsuka. Here you can find the debates and conversations we had during the event....

One of the largest pharmaceutical companies enters the precision cancer study IMPRESS in Norway.

Five new partners have joined CONNECT.

Watch the engaging presentations from the first CONNECT educational seminar for the Norwegian oncology community. CONNECT Working Group 1...

Learn more about the use of real-world data (RWD) for regulatory processes from two presentations held at a recent CONNECT meeting.

Learn more about Horizon Scanning Methods from the presentations held at a recent CONNECT meeting.

Roche is the first pharmaceutical company included in the national clinical study in cancer precision medicine called IMPRESS-Norway.